- Home
- Publications
- Publication Search
- Publication Details
Title
Intratumoral immunotherapy for melanoma
Authors
Keywords
CIMT 2014, Intratumoral, Immunotherapy, Melanoma, Vaccine, Immunoagonists, Oncolytic viruses
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 64, Issue 7, Pages 911-921
Publisher
Springer Nature
Online
2015-06-06
DOI
10.1007/s00262-015-1727-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New perspectives on type I IFNs in cancer
- (2015) Thomas F. Gajewski et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The STING pathway and the T cell-inflamed tumor microenvironment
- (2015) Seng-Ryong Woo et al. TRENDS IN IMMUNOLOGY
- Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity
- (2015) Kevin Van der Jeught et al. Oncotarget
- Intratumoral Immunization: A New Paradigm for Cancer Therapy
- (2014) A. Marabelle et al. CLINICAL CANCER RESEARCH
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation
- (2014) Manisha Singh et al. JOURNAL OF IMMUNOLOGY
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Pilot study of intratumoral injection of recombinant heat shock protein 70 in the treatment of malignant brain tumors in children
- (2014) Maxim Shevtsov et al. OncoTargets and Therapy
- Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
- (2014) Jianfang Ning et al. Frontiers in Microbiology
- STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
- (2014) T. Ohkuri et al. Cancer Immunology Research
- Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19-IL2 Results in Sustained Clinical and Systemic Immunologic Responses
- (2014) B. Weide et al. Cancer Immunology Research
- Therapeutic In Situ Autovaccination against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis, and Clinical Trial
- (2014) A. M. Salazar et al. Cancer Immunology Research
- Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo
- (2014) Linda C Sandin et al. OncoImmunology
- Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
- (2013) B. Kwong et al. CANCER RESEARCH
- Intratumoral Anti-CTLA-4 Therapy: Enhancing Efficacy While Avoiding Toxicity
- (2013) A. Marabelle et al. CLINICAL CANCER RESEARCH
- Turning Tumors into Vaccines: Co-opting the Innate Immune System
- (2013) Jasper G. van den Boorn et al. IMMUNITY
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
- (2013) Johannes vom Berg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Oligodeoxynucleotides Expressing Polyguanosine Motifs Promote Antitumor Activity through the Upregulation of IL-2
- (2013) N. Kobayashi et al. JOURNAL OF IMMUNOLOGY
- Intralesional immunotherapy for melanoma
- (2013) Peter Hersey et al. JOURNAL OF SURGICAL ONCOLOGY
- Inhibition of IL-17A in Tumor Microenvironment Augments Cytotoxicity of Tumor-Infiltrating Lymphocytes in Tumor-Bearing Mice
- (2013) Keiji Hayata et al. PLoS One
- Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines
- (2013) Barbara A. Fox et al. TRENDS IN PARASITOLOGY
- Intratumoral injection of attenuated Salmonella vaccine can induce tumor microenvironmental shift from immune suppressive to immunogenic
- (2013) Eun-Hye Hong et al. VACCINE
- Local immunomodulation for cancer therapy: Providing treatment where needed
- (2013) Marieke Fransen et al. OncoImmunology
- Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma
- (2012) J Doukas et al. CANCER GENE THERAPY
- Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
- (2012) I. Diaconu et al. CANCER RESEARCH
- Viruses in cancer treatment
- (2012) R. Alemany Clinical & Translational Oncology
- Local Delivery of lnterleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice
- (2012) D. Chinnasamy et al. CLINICAL CANCER RESEARCH
- Oncolytic Vaccinia virus safely and effectively treats skin tumors in mouse models of xeroderma pigmentosum
- (2012) Jan Brun et al. INTERNATIONAL JOURNAL OF CANCER
- Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
- (2012) Barbara Drobits et al. JOURNAL OF CLINICAL INVESTIGATION
- TRAIL+ Human Plasmacytoid Dendritic Cells Kill Tumor Cells In Vitro: Mechanisms of Imiquimod- and IFN- -Mediated Antitumor Reactivity
- (2012) M. L. Kalb et al. JOURNAL OF IMMUNOLOGY
- Immune-Mediated Regression of Established B16F10 Melanoma by Intratumoral Injection of Attenuated Toxoplasma gondii Protects against Rechallenge
- (2012) J. R. Baird et al. JOURNAL OF IMMUNOLOGY
- Intratumoral hu14.18-IL-2 (IC) Induces Local and Systemic Antitumor Effects That Involve Both Activated T and NK Cells As Well As Enhanced IC Retention
- (2012) R. K. Yang et al. JOURNAL OF IMMUNOLOGY
- Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
- (2012) Y. Shirota et al. JOURNAL OF IMMUNOLOGY
- Combined Intralesional Bacille Calmette-Guérin (BCG) and Topical Imiquimod for In-transit Melanoma
- (2012) Travis B. Kidner et al. JOURNAL OF IMMUNOTHERAPY
- Immunotherapeutic Synergy Between Anti-CD137 mAb and Intratumoral Administration of a Cytopathic Semliki Forest Virus Encoding IL-12
- (2012) José I Quetglas et al. MOLECULAR THERAPY
- The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice
- (2012) Diana M Rommelfanger et al. MOLECULAR THERAPY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- STING and the innate immune response to nucleic acids in the cytosol
- (2012) Dara L Burdette et al. NATURE IMMUNOLOGY
- Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame
- (2012) Marijke van Rikxoort et al. PLoS One
- Plasmid IL-12 electroporation in melanoma
- (2012) Edward Cha et al. Human Vaccines & Immunotherapeutics
- Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
- (2011) Sally M. Amos et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune Adjuvant Efficacy of CpG Oligonucleotide in Cancer Treatment Is Founded Specifically upon TLR9 Function in Plasmacytoid Dendritic Cells
- (2011) S. Nierkens et al. CANCER RESEARCH
- Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses
- (2011) M. B. Davis et al. CLINICAL CANCER RESEARCH
- Role of bacillus Calmette–Guérin in the treatment of advanced melanoma
- (2011) John H Stewart et al. Expert Review of Anticancer Therapy
- Measles virus causes immunogenic cell death in human melanoma
- (2011) O G Donnelly et al. GENE THERAPY
- Activating Systemic T-Cell Immunity Against Self Tumor Antigens to Support Oncolytic Virotherapy with Vesicular Stomatitis Virus
- (2011) Phonphimon Wongthida et al. HUMAN GENE THERAPY
- Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope Glycoproteins
- (2011) Camilo Ayala-Breton et al. HUMAN GENE THERAPY
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Antitumor Activity Mediated by CpG
- (2011) Yanyan Lou et al. JOURNAL OF IMMUNOTHERAPY
- Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
- (2011) A. Carpentier et al. NEURO-ONCOLOGY
- Vaccine adjuvant activity of 3M-052: An imidazoquinoline designed for local activity without systemic cytokine induction
- (2011) Dmitri Smirnov et al. VACCINE
- Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18
- (2011) Gough G Au et al. Virology Journal
- IFN Markedly Cooperates with Intratumoral Dendritic Cell Vaccine in Dog Tumor Models
- (2010) K. Mito et al. CANCER RESEARCH
- A Critical Role for Mast Cells and Mast Cell-Derived IL-6 in TLR2-Mediated Inhibition of Tumor Growth
- (2010) S. A. Oldford et al. JOURNAL OF IMMUNOLOGY
- Intratumoral Interleukin-21 Increases Antitumor Immunity, Tumor-infiltrating CD8+ T-cell Density and Activity, and Enlarges Draining Lymph Nodes
- (2010) Henrik Søndergaard et al. JOURNAL OF IMMUNOTHERAPY
- Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2
- (2010) Tomoko Hayashi et al. MELANOMA RESEARCH
- Potentiating Cancer Immunotherapy Using an Oncolytic Virus
- (2010) Byram W Bridle et al. MOLECULAR THERAPY
- VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 Signaling
- (2010) Phonphimon Wongthida et al. MOLECULAR THERAPY
- Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors
- (2010) Heather MacTavish et al. PLoS One
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Antitumoral Immune Response by Recruitment and Expansion of Dendritic Cells in Tumors Infected with Telomerase-Dependent Oncolytic Viruses
- (2009) Edukulla Ramakrishna et al. CANCER RESEARCH
- Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication
- (2009) R. J. Prestwich et al. CLINICAL CANCER RESEARCH
- Treatment of cutaneous tumors with topical 5% imiquimod cream
- (2009) Sabrina Sisto Alessi et al. Clinics
- Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus
- (2009) Feorillo Galivo et al. HUMAN GENE THERAPY
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate
- (2009) Günther F.L. Hofbauer et al. MELANOMA RESEARCH
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
- (2009) Hiroki Ishikawa et al. NATURE
- Route of Administration of the TLR9 Agonist CpG Critically Determines the Efficacy of Cancer Immunotherapy in Mice
- (2009) Stefan Nierkens et al. PLoS One
- Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma
- (2009) Geoffrey W. Stone et al. PLoS One
- STING-ing the Antiviral Pathway
- (2009) P. Nakhaei et al. Journal of Molecular Cell Biology
- Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
- (2008) R. J. Prestwich et al. CLINICAL CANCER RESEARCH
- Phase 1 Evaluation of Intralesionally Injected TLR9-agonist PF-3512676 in Patients With Basal Cell Carcinoma or Metastatic Melanoma
- (2008) Maja A. Hofmann et al. JOURNAL OF IMMUNOTHERAPY
- Intralesional Adenovirus-mediated Interleukin-2 Gene Transfer for Advanced Solid Cancers and Melanoma
- (2008) Reinhard Dummer et al. MOLECULAR THERAPY
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
- Myxoma Virus Oncolysis of Primary and Metastatic B16F10 Mouse Tumors In Vivo
- (2007) Marianne M Stanford et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search